Aderis Pharmaceuticals - Ownership and Business Overview

Healthcare ServicesCompany

Aderis Pharmaceuticals Ownership

Who owns Aderis Pharmaceuticals?

Aderis Pharmaceuticals is owned by Schwarz Pharma. It was acquired on July 15, 2005.

Aderis Pharmaceuticals Business Overview

Where is Aderis Pharmaceuticals headquartered?

Aderis Pharmaceuticals is headquartered in Hopkinton, Massachusetts.

What sector is Aderis Pharmaceuticals in?

Aderis Pharmaceuticals is a healthcare services company.

When was Aderis Pharmaceuticals founded?

Aderis Pharmaceuticals was founded in 1994.

Healthcare Services M&A Summary in 2005

Out of 60 sectors in the Mergr database, healthcare services ranked 5 in number of deals in 2005. The largest healthcare services acquisition in 2005 was Renal Care Group - which was acquired by Fresenius Medical Care AG KGaA for $3.5B.

Join Mergr to view all 125 acquisitions of healthcare services companies in 2005, including 47 acquisitions by private equity firms, and 78 by strategics.

Aderis Pharmaceuticals, Inc.

85 Main Street,
Hopkinton, Massachusetts 01748
United States,

Aderis Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development, manufacture, and commercialization of pharmaceuticals for the therapeutic treatment of central nervous system, cardiovascular, and inflammatory diseases.


 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.